Accessible surface area
Breakup changes accessibility; crystal shrinkage reduces area.
Shear changes structure. Structure changes dissolution.
Explore the link from deflocculation to accessible surface area and in-vitro dissolution. Compare the mechanistic model with the published observations.
Flocculation is the reversible association of small solid particles into loose clusters. The primary crystals remain distinct, with liquid between them.
Controlled flocculation can improve physical stability on the shelf: an open sediment is less prone to packing into a hard cake and can be easier to redisperse.
Loose association
Weak particle interactions form an open network.
Lower caking risk
Liquid-filled spaces help resist tight, irreversible packing.
Redispersibility
Mixing can redistribute flocs through the liquid.
Flocs may settle faster than individual particles. Formulation design balances settling, caking risk and redispersibility—and that same structure can influence dissolution.
Scientific context: Smith et al., 2021 · Introduction & section 3.5Small solid particles are distributed through the liquid.
Conceptual animation with accelerated stages. It does not calculate settling time, caking or shelf life. Dashed links indicate reversible association.
Change a pre-shear pulse, then follow structure and dissolution after dilution. Compare with a sample given the same waiting time and vessel conditions, without the pulse.
Illustrative particles. Layout conveys the dispersion index, not tracked trajectories; crystal size follows simulated shrinkage. Deflocculation exposes existing surface—it does not fracture crystals.
Breakup changes accessibility; crystal shrinkage reduces area.
Noyes–Whitney flux at the current area and concentration.
Same dose, volume, solubility and vessel shear in both samples.
The dissolution rate follows dMd/dt = k Aeff(Cs − C), where k = D/h. Here k stays fixed to isolate surface accessibility. Agitation can also change mass transfer in real experiments.
The pulse changes the initial dispersion index. Breakup and re-flocculation then compete under the same background shear in both samples.
If liquid already reaches all primary surfaces inside a floc, breakup need not increase effective area. Set internal access to 100% to explore this limiting case.
Solid mass and crystal size decrease. Concentration approaches solubility, reducing Cs − C. In a saturated vessel, increasing surface area cannot overcome the equilibrium limit.
df/dt = kb g² (1 − f) − (ka0 + ka1 g) (Ms/M₀) f
f is a mean-field dispersion/exposure index, not a measured particle-count fraction. g = G/Gref is relative shear intensity. The quadratic breakup and concentration-dependent first-order re-flocculation proxy are declared assumptions. They are inspired by competing aggregation/breakup models, not equations fitted to this suspension or copied from the paper. During preconditioning, solid mass is held fixed; dissolution starts at dilution. The reference sample undergoes the same wait at g = 0.
x = (Ms/M₀)1/3; Afree = 6M₀ x²/(ρd₀)χ = 1/F + p(1 − 1/F); Aeff = Afree[χ + (1 − χ)f]
F is the compact-equivalent floc-to-primary diameter ratio. For F³ identical primaries, the compact-envelope area divided by their separate total area is 1/F. Parameter p adds internal surface access, from 0 (shielded limit) to 1 (all primary surfaces accessible). This is an idealized shielding model; porous real flocs need not behave as compact spheres. Uniform spherical primary-crystal shrinkage is a mean-field approximation, not a full size-resolved population balance.
dMd/dt = k Aeff max(Cs − Md/V, 0); Ms + Md = M₀
k is an effective mass-transfer coefficient (D/h). Volume, solubility, density and k are constant; the vessel is well mixed. No removal, replacement, absorption or in-vivo extrapolation is included. Breakup does not create drug mass or smaller primary crystals. The numerical solver evolves x and f, checks physical bounds and reports rates from the same state as the charts.
The 2 µm primary size, approximately 15 µg/mL water solubility, 150 mL test volume and 1.32 mg dose (33 µL × 40 mg/mL) are informed by the 2021 study. Density, floc factor, internal access, dispersion index, kinetic coefficients and k are illustrative assumptions. The simulator is not calibrated to its dissolution, D10 or obscuration curves. Its x-derived diameter is a model primary diameter, not measured D10 or a recreated PSD.
Related scientific basis: Serra & Casamitjana: shear-dependent aggregation and breakup; Gao et al.: diffusion-based, non-sink dissolution modeling. Their calibrated material parameters are not transferred to triamcinolone here.
The deterministic solver uses fourth-order Runge–Kutta with a default 0.05-second step and a separate 0.05-minute output grid. Unit, mass-balance, limiting-case, analytical structural-relaxation and time-step-refinement checks accompany the maintained implementation. These numerical checks verify the model calculation; experimental calibration remains a separate step.
Published observations · Product 3 · Figure 7A–C · 0.5–15 min
One shared time cursor. Two introduction conditions.
Stirring held at 500 rpm.
Fiber-optic UV · fraction of drug dissolved
Laser diffraction · volume-based lower size percentile
Optical signal · not an absolute particle count
Blue circles: lower-shear micropipette introduction. Coral triangles: higher-shear syringe introduction. Faint traces show the rest of the digitized figure window; bright traces follow the selected time. Values describe this experiment, not a predicted patient response.
Fiber-optic UV tracks drug in solution. The two curves separate early even though they start with the same product.
D10 is the diameter below which 10% of the measured particle volume falls. A changing D10 does not tell us the path of any individual particle.
Laser light obscuration depends on the particles and how they scatter light. It reveals changes in the particulate signal, rather than an exact number of particles.
The authors propose slow erosion of initially flocculated material for the low-shear condition, and competing dissolution and re-flocculation for the high-shear condition. Those are interpretations of the combined signals—not observed tracks of individual particles.
Figure 7A–C, representative Product 3, from Smith et al. (2021), Impact of particle flocculation on the dissolution and bioavailability of injectable suspensions. The tandem laser-diffraction / fiber-optic UV experiment used 150 mL medium and a 33 µL sample; section 3.3 identifies 500 rpm as the lowest stirring rate maintaining circulation.
Curves were digitized from vector paths in the supplied publication PDF, page 8. They are approximate published-figure values, not the original instrument data or a fitted kinetic model. Common window: 0.5–15 minutes. Full size distributions, the plotted dissolution-rate derivative, later observations and error/replicate estimates are not reconstructed.
The source uses linear time in panel A and logarithmic time in panels B/C. Axis calibration was performed separately; the replay uses a common linear time axis. Window endpoints can be intersections with a plotted connecting line. Cursor values use linear interpolation in time between digitized vertices. Display precision does not establish measurement uncertainty.
Changing the cursor replays the selected experiment. It does not predict dissolution from needle gauge, infusion rate or stirring speed. A 2026 follow-up by Kakhi & Smith reports that appreciable clinical variability remains even when needle gauge is controlled. The present experience makes no clinical dosing, absorption or bioavailability prediction.
Source review: relevant methods, section 3.3 and Figure 7 visually inspected. The follow-up’s abstract was reviewed; its full text was not acquired. The reconstruction uses the publication figure; original numerical records and supplemental time series were not available for this version.
Download digitized figure data